Biotechnology
Swiss companies operating in the same biotechnology industry
The table below has Swiss companies that operate under the same industry, biotechnology. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Lonza Group AG, or spot the most traded options, such as MindMaze Therapeutics Holding SA. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAmgen Inc. | 165.81 B CHF | 297.069 CHF | +1.73% | 1 | 0.48 | 25.85 | 11.49 CHF | +18.50% | 2.61% | Health technology | Buy |
 LONNLonza Group AG | 37.35 B CHF | 548.0 CHF | +1.07% | 114.52 K | 0.69 | — | −1.55 CHF | −115.18% | 0.91% | Health technology | Buy |
| LO3Lonza Group AG | 37.35 B CHF | 548.360 CHF | +1.21% | 42 | 0.27 | — | −1.55 CHF | −115.18% | 0.91% | Health technology | Buy |
 QTSIQVIA Holdings Inc | 28.37 B CHF | 160.066 CHF | +24.87% | 18 | — | 24.83 | 6.45 CHF | −0.74% | 0.00% | Health technology | Buy |
 22UABioNTech SE Sponsored ADRDR | 18.46 B CHF | 74.141 CHF | −1.14% | 26 | 1.07 | — | −4.69 CHF | −54.27% | 0.00% | Health technology | Buy |
 0QFModerna, Inc. | 17.53 B CHF | 44.369 CHF | −5.15% | 107 | 1.00 | — | −6.51 CHF | +15.69% | 0.00% | Health technology | Neutral |
| MRNA.USDModerna, Inc. | 17.53 B CHF | 47.200 USD | 0.00% | 7.9 K | 6.15 | — | −6.51 CHF | +6.61% | 0.00% | Health technology | Neutral |
 BM8BioMarin Pharmaceutical Inc. | 9.37 B CHF | 47.379 CHF | +9.65% | 10 | 0.01 | 43.26 | 1.10 CHF | −54.09% | 0.00% | Health technology | Buy |
 1CGCRISPR Therapeutics AG | 3.67 B CHF | 38.932 CHF | −4.25% | 450 | 1.07 | — | −4.96 CHF | −24.18% | 0.00% | Health technology | Buy |
 PPGNPolyPeptide Group AG | 1.44 B CHF | 43.75 CHF | −0.11% | 161.98 K | 0.74 | — | −0.61 CHF | −7.03% | 0.00% | Health technology | Buy |
| 8H0PolyPeptide Group AG | 1.44 B CHF | 41.765 CHF | −8.85% | 212 | 1.09 | — | −0.61 CHF | −7.03% | 0.00% | Health technology | Buy |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1.28 B CHF | 2.500 CHF | +6.38% | 500 | 0.36 | — | −0.96 CHF | +38.93% | 0.00% | Health technology | Buy |
 38IIntellia Therapeutics, Inc. | 1.22 B CHF | 9.231 CHF | −16.01% | 300 | 0.49 | — | −2.82 CHF | +38.99% | 0.00% | Health technology | Buy |
 VIRVir Biotechnology, Inc. | 1.2 B CHF | 7.638 CHF | +0.16% | 250 | — | — | −2.51 CHF | +32.95% | 0.00% | Health technology | Strong buy |
 KURNKuros Biosciences Ltd. | 781.28 M CHF | 19.80 CHF | −2.75% | 141.42 K | 1.25 | 430.43 | 0.05 CHF | — | 0.00% | Health technology | Strong buy |
| YTSNKuros Biosciences Ltd. | 781.28 M CHF | 19.939 CHF | −3.83% | 22 | 0.10 | 433.46 | 0.05 CHF | — | 0.00% | Health technology | Strong buy |
 BIOVBioVersys AG | 159.83 M CHF | 27.3 CHF | −0.36% | 5 | 0.01 | — | −3.90 CHF | −21.73% | 0.00% | Health technology | Strong buy |
 6MLMolecular Partners AG | 128.39 M CHF | 3.205 CHF | +0.34% | 88 | 0.38 | — | −1.55 CHF | +9.23% | 0.00% | Health technology | Strong buy |
| MOLNMolecular Partners AG | 128.39 M CHF | 3.18 CHF | −1.55% | 4.18 K | 0.38 | — | −1.55 CHF | +9.23% | 0.00% | Health technology | Strong buy |
 MMTXMindMaze Therapeutics Holding SA | 28.44 M CHF | 0.163 CHF | −57.66% | 6 K | — | — | — | — | 0.00% | Health technology | No rating |
| MMTXMindMaze Therapeutics Holding SA | 28.44 M CHF | 0.1580 CHF | +3.67% | 931.24 K | 0.96 | — | — | — | 0.00% | Health technology | No rating |